Commission Implementing Regulation (EU) 2026/2526 of 13 November 2026 cancelling the Union authorisation for the single biocidal product Manorapid express GEL in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2023/1106
Article 1
In force · version of Dec 6, 2026
The Union authorisation for the single biocidal product ‘Manorapid express GEL’ granted by Implementing Regulation (EU) 2023/1106 to Lysoform Dr Hans Rosemann GmbH with the authorisation number EU-0027675-0000 is cancelled.